RxDoctor Payments Data

Shauna Johnson, APRN

Family · Hodgenville, KYNPI 1699291211

Payments from drug & device makers

$3,272in general payments, 2019–2025

Across 207 payments — averaging $15.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$459
  • AbbVie$434
  • Lilly USA, LLC$400
  • Pfizer$290
  • Bayer$155
  • Shield Therapeutics Inc$152
  • plus $1K from 27 others

What the payments were for

  • Food & beverage$3,272100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,272 in reported general payments places this provider in the 85th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$2,626
Medicare patients
89
Services billed
125

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide74$89,022
OzempicSemaglutide46$52,802
TrulicityDulaglutide40$45,031
Trelegy ElliptaFluticasone/Umeclidin/Vilanter48$36,360
LinzessLinaclotide45$26,630
EliquisApixaban20$19,521
XareltoRivaroxaban33$18,456
JanuviaSitagliptin Phosphate24$16,522
FarxigaDapagliflozin Propanediol30$15,833
Breztri AerosphereBudesonide/Glycopyr/Formoterol15$12,821
Combivent RespimatIpratropium/Albuterol Sulfate17$8,078
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$5,138
Ondansetron Hcl27$3,564
Albuterol Sulfate HfaAlbuterol Sulfate143$3,017
Levothyroxine Sodium350$2,406

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$400$134,054114 claims
Novo NordiskOzempic$459$52,80246 claims
GSKTrelegy Ellipta, Anoro Ellipta$123$41,49859 claims
AstraZenecaFarxiga, Breztri Aerosphere$108$28,65345 claims
AbbVieLinzess, Synthroid$434$27,23665 claims
PfizerEliquis$290$19,52120 claims
MerckJanuvia$33$16,52224 claims
Boehringer IngelheimCombivent Respimat$15$8,07817 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,374 family providers in Kentucky.

Other family in Hodgenville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →